Cyclin-dependent kinase 4/6 inhibitor ribociclib-induced colitis with a successful transition to palbociclib.

已完结 10 由阿雷发布于 2026/1/26 9:08:50

DOI:10.1136/bcr-2024-263176
作者：Ishitha Jagadish,?Phoebe Newell,?Hung Thieu Khong
文献类型：期刊论文
补充材料：只需要正文

BMJ

Abstract：Cyclin-dependent kinase 4/6 inhibitors (CDK4/6Is), including ribociclib, are used alongside endocrine therapy for hormone receptor-positive (HR+) and human epidermal growth factor receptor 2

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierFishing or farming? Isotopic evidence of human subsistence strategies at the Dashuitian site during the middle Neolithic in the Three Gorges of the Yangtze River, China